Amgen, Novartis collaborate for Alzheimer’s disease and migraine programs

Posted in: Business / Finance | Medical Condition News

Tags: Alzheimer’s Disease, Antibody, Beta Amyloid, biology, Biotechnology, Brain, Calcitonin, Cell, Cell Culture, Dementia, Disability, Gene, Genetic, Genetics, Headache, Healthcare, Managed Care, Migraine, Monoclonal Antibody, Nausea, Neurodegenerative Disease, Neuroscience, Pain, Placebo, Protein, Stroke, therapeutics, Vomiting